ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Keith B. Allen
Robert D. Dowling
Wayne Richenbacher
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allen, K. B.
Right arrow Articles by Richenbacher, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allen, K. B.
Right arrow Articles by Richenbacher, W.
Related Collections
Right arrow Coronary disease
Right arrowRelated Article

Ann Thorac Surg 2005;79:2200-2201
© 2005 The Society of Thoracic Surgeons

Correspondence

Reply

Keith B. Allen, MDa, Robert D. Dowling, MDb, Wayne Richenbacher, MDc

a Indiana Heart Institute, 8333 Naab Rd, Suite 300, Indianapolis, IN 46290
b Jewish Heart and Lung Institute, 201 Abraham Flexner Way, Suite 1200, Louisville, KY 40202
c University of Iowa Hospital, 200 Hawkins Dr, Iowa City, IA 52242

(E-mail: wayne-richenbacher@uiowa.edu).

The first 20% of the full text of this article appears below.

To the Editor:

Doctor Furnary, a proponent and user of CO2 TMR, has requested clarification of our recently published 5-year follow-up of "no option" class IV angina patients prospectively randomly assigned to holmium:YAG TMR or continued medical management. As a longitudinal follow-up of a prospectively conducted 1-year trial [1], our goal was to obtain long-term assessments that could be made in a high proportion of patients and with a high degree of confidence: masked angina assessment independent of study investigators and survival. Centers that participated in the original trial and who were capable of providing this long-term assessment obtained follow-up in 77% of originally . . . [Full Text of this Article]


Related Article

What Are the Real (Non-Intent to Treat—Isolated Sole Therapy) 5-Year Results of Ho:YAG TMR Therapy?
Anthony P. Furnary
Ann. Thorac. Surg. 2005 79: 2200. [Extract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The Society of Thoracic Surgeons.